Prognostic factors of papillary and follicular carcinomas in Japan based on data of Kuma Hospital

Journal of Thyroid Research

Volumn 2012, Issue , 2012, Pages

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYCLINE; GLUTAMIC ACID; KI 67 ANTIGEN; THYMINE; VALINE;

AMINO ACID SUBSTITUTION; BRAF GENE; CANCER CELL; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFERENTIATED THYROID CANCER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; GENE; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; JAPAN; LYMPH NODE METASTASIS; MITOSIS; NECK DISSECTION; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POORLY DIFFERENTIATED THYROID CANCER; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID PARAFOLLICULAR CELL;

EID: 84859466508     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2012/973497     Document Type: Review

References (131)

1. Ito T., Seyama T., Mizuno T., Tsuyama N., Hayashi T., Hayashi Y., Dohi K., Nakamura N., Akiyama M., Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Research 1992 52 5 1369 1371 2-s2.0-0026575904
2. Sakamoto A., Kasai N., Sugano H., Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983 52 10 1849 1855 2-s2.0-0021055244 (Pubitemid 14228153)
3. Carcangiu M. L., Zampi G., Rosai J., Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans' 'wuchernde struma'. American Journal of Surgical Pathology 1984 8 9 655 668 2-s2.0-0021165886 (Pubitemid 14068779)
4. Sobrinho-Simoes M., Carcangiu M. L., Albores-Saavedra J., DeLeillis R. A., Lloyd R. V., Heitz P. U., Poorly differentiated carcinoma. Pathology and Genetics of Tumous of Endocrine Organs 2004 Lyon, France IARC Press 73 76
5. The Japanese Society of Thyroid Surgery, General Rules for the Description of Thyroid Cancer 2005 6th Tokyo, Japan Kanehara Press
6. Volante M., Collini P., Nikiforov Y. E., Sakamoto A., Kakudo K., Katoh R., Lloyd R. V., LiVolsi V. A., Papotti M., Sobrinho-Simoes M., Bussolati G., Rosai J., Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. American Journal of Surgical Pathology 2007 31 8 1256 1264 2-s2.0-34248177447 10.1097/PAS.0b013e3180309e6a (Pubitemid 47207131)
7. Ito Y., Amino N., Yokozawa T., Ota H., Ohshita M., Murata N., Morita S., Kobayashi K., Miyauchi A., Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 2007 17 12 1269 1276 2-s2.0-37849020497 10.1089/thy.2007.0014
8. Antonelli A., Miccoli P., Ferdeghini M., Di Coscio G., Alberti B., Iacconi P., Baldi V., Fallahi P., Baschieri L., Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 1995 5 1 25 28 2-s2.0-0028959620
9. Uruno T., Miyauchi A., Shimizu K., Tomoda C., Takamura Y., Ito Y., Miya A., Kobayashi K., Matsuzuka F., Amino N., Kuma K., Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World Journal of Surgery 2005 29 4 483 485 2-s2.0-23444452083 10.1007/s00268-004-7701-0 (Pubitemid 41125373)
10. Cady B., Rossi R., Hay I., Cohn K. H., Thompson N. W., An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988 104 6 947 953 2-s2.0-0024232116 (Pubitemid 19011971)
11. Sobin L. H., Wittekindeds C. H., UICC; TNM Classification of Malignant Tumors 2002 6th New York, NY, USA Wiley-Liss
12. Sugitani I., Kasai N., Fujimoto Y., Yanagisawa A., A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004 135 2 139 148 2-s2.0-1642560946 10.1016/S0039-6060(03)00384-2 (Pubitemid 38130764)
13. Hay I. D., Bergstralh E. J., Goellner J. R., Ebersold J. R., Grant C. S., Carty S. E., Geelhoed G. W., Rosen I. B., Cady B., Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 114 6 1050 1058 2-s2.0-0027135424 (Pubitemid 24004722)
14. Ito Y., Ichihara K., Masuoka H., Fukushima M., Inoue H., Kihara M., Tomoda C., Higashiyama T., Takamura Y., Kobayashi K., Miya A., Miyauchi A., Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World Journal of Surgery 2010 34 11 2570 2580 2-s2.0-78549255183 10.1007/s00268-010-0710-2
15. Ito Y., Miyauchi A., Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocrine Journal 2008 56 2 177 192 2-s2.0-66849089759 10.1507/endocrj.K08E-166
16. Passler C., Scheuba C., Prager G., Kaczirek K., Kaserer K., Zettinig G., Niederle B., Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocrine-Related Cancer 2004 11 1 131 139 2-s2.0-1842419703 10.1677/erc.0.0110131 (Pubitemid 38419728)
17. Gilliland F. D., Hunt W. C., Morris D. M., Key C. R., Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 19731991. Cancer 1997 79 3 564 573 2-s2.0-0031028402 10.1002/(SICI)1097-0142(19970201)79:3564::AID- CNCR20>3.0.CO;2-0 (Pubitemid 27051783)
18. Kim T. Y., Hong S. J., Kim J. M., Gu Kim W., Gong G., Ryu J. S., Kim W. B., Yun S. C., Shong Y. K., Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 2008 14 8 296 2-s2.0-55649121110 10.1186/1471-2407-8-296
19. Fagin J. A., Familial nonmedullary thyroid carcinomathe case for genetic susceptibility. Journal of Clinical Endocrinology and Metabolism 1997 82 2 342 344 2-s2.0-0031032352 10.1210/jc.82.2.342 (Pubitemid 27068588)
20. Sturgeon C., Clark O. H., Familial nonmedullary thyroid cancer. Thyroid 2005 15 6 588 593 2-s2.0-22244462432 10.1089/thy.2005.15.588 (Pubitemid 40993733)
21. Robinson D. W., Orr T. G., Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Archive of Surgery 1955 70 6 923 928
22. Nemec J., Soumar J., Zamrazil V., Familial occurrence of differential (non medullary) thyroid cancer. Oncology 1975 32 3-4 151 157 2-s2.0-0016588830
23. Pal T., Vogl F. D., Chappuis P. O., Tsang R., Brierley J., Renard H., Sanders K., Kantemiroff T., Bagha S., Goldgar D. E., Narod S. A., Foulkes W. D., Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 11 5307 5312 2-s2.0-17944369099 10.1210/jc.86.11.5307 (Pubitemid 33070252)
24. Goldgar D. E., Easton D. F., Cannon-Albright L. A., Skolnick M. H., Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute 1994 86 21 1600 1608 2-s2.0-0028143018 (Pubitemid 24336346)
25. Grossman R. F., Tu S. H., Duh Q. Y., Siperstein A. E., Novosolov F., Clark O. H., Schmidt N., Danto L. A., Giuliano A. E., Smith M. P., Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Archives of Surgery 1995 130 8 892 899 2-s2.0-0029074897
26. Triponez F., Wong M., Sturgeon C., Caron N., Ginzinger D. G., Segal M. R., Kebebew E., Duh Q. Y., Clark O. H., Does familial non-medullary thyroid cancer adversely affect survival? World Journal of Surgery 2006 30 5 787 793 2-s2.0-33646549545 10.1007/s00268-005-0398-x (Pubitemid 43724107)
27. Loh K. C., Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 1997 7 1 107 113 2-s2.0-0030896374
28. Leprat F., Bonichon F., Guyot M., Trouette H., Trojani M., Vergnot V., Longy M., Belleannée G., De Mascarel A., Roger P., Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clinical Endocrinology 1999 50 5 589 594 2-s2.0-0032964562 10.1046/j.1365-2265.1999.00687.x (Pubitemid 29236335)
29. Lupoli G., Vitale G., Caraglia M., Fittipaldi M. R., Abbruzzese A., Tagliaferri P., Bianco A. R., Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999 353 9153 637 639 2-s2.0-0033060520 10.1016/S0140-6736(98)08004-0 (Pubitemid 29087985)
30. Maxwell E. L., Hall F. T., Freeman J. L., Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 2004 114 12 2182 2186 2-s2.0-10044265650 10.1097/01.mlg.0000149454.91005.65 (Pubitemid 39602485)
31. Uchino S., Noguchi S., Kawamoto H., Yamashita H., Watanabe S., Yamashita H., Shuto S., Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World Journal of Surgery 2002 26 8 897 902 2-s2.0-0036691719 10.1007/s00268-002-6615-y (Pubitemid 36920283)
32. Ito Y., Kakudo K., Hirokawa M., Fukushima M., Yabuta T., Tomoda C., Inoue H., Kihara M., Higashiyama T., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 2009 145 1 100 105 2-s2.0-57149113140 10.1016/j.surg.2008.08.004
33. Ito Y., Uruno T., Nakano K., Takamura Y., Miya A., Kobayashi K., Yokozawa T., Matsuzuka F., Kuma S., Kuma K., Miyauchi A., An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003 13 4 381 387 2-s2.0-0038702077 (Pubitemid 36588523)
34. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Papillary microcarcinoma of the thyroid: how should it be treated? World Journal of Surgery 2004 28 11 1115 1121 2-s2.0-12144284838 10.1007/s00268-004-7644-5 (Pubitemid 40109861)
35. Ito Y., Miyauchi A., A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nature Clinical Practice Endocrinology and Metabolism 2007 3 3 240 248 2-s2.0-33847187769 10.1038/ncpendmet0428
36. Ito Y., Miyauchi A., Inoue H., Fukushima M., Kihara M., Higashiyama T., Tomoda C., Takamura Y., Kobayashi K., Miya A., An observational trial for papillary thyroid microcarcinoma in Japanese patients. World Journal of Surgery 2010 34 1 28 35 2-s2.0-73649127207 10.1007/s00268-009-0303-0
37. Sugitani I., Toda K., Yamada K., Yamamoto N., Ikenaga M., Fujimoto Y., Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World Journal of Surgery 2010 34 6 1222 1231 2-s2.0-77955557317 10.1007/s00268-009-0359-x
38. Harach H. R., Franssila K. O., Wasenius V. M., Occult papillary carcinoma of the thyroid. A 'normal' finding in Finland. A systematic autopsy study. Cancer 1985 56 3 531 538 2-s2.0-0021809472 (Pubitemid 15035581)
39. Fukunaga F. H., Yatani R., Geographic pathology of occult thyroid carcinomas. Cancer 1975 36 3 1095 1099 2-s2.0-0016712409
40. Thorvaldsson S. E., Tulinius H., Bjornsson J., Bjarnason O., Latent thyroid carcinoma in Iceland at autopsy. Pathology Research and Practice 1992 188 6 747 750 2-s2.0-0026760287
41. Takebe K., Date M., Yamamoto Y., Mass screening for thyroid cancer with ultrasonography KARKINOS 1994 7 4 309 317
42. Ito Y., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World Journal of Surgery 2007 31 11 2085 2091 2-s2.0-35448963028 10.1007/s00268-007-9224-y (Pubitemid 47620236)
43. Sugitani I., Fujimoto Y., Yamada K., Yamamoto N., Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World Journal of Surgery 2008 32 11 2494 2502 2-s2.0-53949083518 10.1007/s00268-008-9711-9
44. Ito Y., Masuoka H., Fukushima M., Inoue H., Kihara M., Tomoda C., Higashiyama T., Takamura Y., Kobayashi K., Miya A., Miyauchi A., Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World Journal of Surgery 2010 34 6 1285 1290 2-s2.0-77955552112 10.1007/s00268-009-0356-0
45. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World Journal of Surgery 2004 28 5 498 501 2-s2.0-2442643855 10.1007/s00268-004-7192-z (Pubitemid 38668483)
46. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World Journal of Surgery 2005 29 7 917 920 2-s2.0-27744465193 10.1007/s00268-005-7789-x (Pubitemid 41800728)
47. Ito Y., Miyauchi A., Jikuzono T., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Ichihara K., Kuma K., Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World Journal of Surgery 2007 31 4 838 848 2-s2.0-33947709904 10.1007/s00268-006-0455-0 (Pubitemid 46496217)
48. Ito Y., Miyauchi A., Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World Journal of Surgery 2007 31 5 905 915 2-s2.0-34248184147 10.1007/s00268-006-0722- 0 (Pubitemid 46716772)
49. Ito Y., Miyauchi A., Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World Journal of Surgery 2008 32 5 729 739 2-s2.0-42449088952 10.1007/s00268-007-9315-9
50. Ito Y., Fukushima M., Tomoda C., Inoue H., Kihara M., Hugashiyama T., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocrine Journal 2009 56 6 759 766 2-s2.0-70349958180 10.1507/endocrj.K09E-025
51. Ito Y., Hirokawa M., Jikuzono T., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World Journal of Surgery 2007 31 6 1194 1201 2-s2.0-34447100136 10.1007/s00268-007-9035-1
52. Pacini F., Cetani F., Miccoli P., Mancusi F., Ceccarelli C., Lippi F., Martino E., Pinchera A., Mazzaferri E. L., Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World Journal of Surgery 1994 18 4 600 604 2-s2.0-0027933714 (Pubitemid 24273863)
53. Shoup M., Stojadinovic A., Nissan A., Ghossein R. A., Freedman S., Brennan M. F., Shah J. P., Shaha A. R., Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. Journal of the American College of Surgeons 2003 197 2 191 197 2-s2.0-0042166011 10.1016/S1072-7515(03)00332-6 (Pubitemid 36927381)
54. Haq M., Harmer C., Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clinical Endocrinology 2005 63 1 87 93 2-s2.0-22044458191 10.1111/j.1365-2265.2005.02304. x (Pubitemid 40966408)
55. Orita Y., Sugitani I., Matsuura M., Ushijima M., Tsukahara K., Fujimoto Y., Kawabata K., Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 2010 147 3 424 431 2-s2.0-76749160633 10.1016/j.surg.2009.10.009
56. Ito Y., Masuoka H., Fukushima M., Inoue H., Kihara M., Tomoda C., Higashiyama T., Takamura Y., Kobayashi K., Miya A., Miyauchi A., Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan. Endocrine Journal 2010 57 6 523 531 2-s2.0-77954751619 10.1507/endocrj.K10E-019
57. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surgery Today 2006 36 1 12 18 2-s2.0-29544439124 10.1007/s00595-005-3090-8 (Pubitemid 43015848)
58. Ito Y., Tomoda C., Uruno T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World Journal of Surgery 2006 30 5 780 786 2-s2.0-33646549546 10.1007/s00268-005-0270-z (Pubitemid 43724106)
59. Fukushima M., Ito Y., Hirokawa M., Miya A., Shimizu K., Miyauchi A., Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size. World Journal of Surgery 2010 34 12 3007 3014 2-s2.0-77956260542 10.1007/s00268-010-0776-x
60. Asanuma K., Kusama R., Maruyama M., Fujimori M., Amano J., Macroscopic extranodal invasion is a risk factor for tumor recurrence in papillary thyroid cancer. Cancer Letters 2001 164 1 85 89 2-s2.0-0035836072 10.1016/S0304-3835(00) 00698-4 (Pubitemid 32144993)
61. Yamashita H., Noguchi S., Murakami N., Kawamoto H., Watanabe S., Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 1997 80 12 2268 2272 2-s2.0-0031454232 10.1002/(SICI)1097-0142(19971215) 80:122268::AID-CNCR8>3.0.CO;2-Q (Pubitemid 28007398)
62. Spires J. R., Robbins K. T., Luna M. A., Byers R. M., Metastatic papillary carcinoma of the thyroid: the significance of extranodal extension. Head and Neck 1989 11 3 242 246 2-s2.0-0024821283 (Pubitemid 20052796)
63. Macdonald I., O'Hara G. L., Weber R. A., Carcinoma of the thyroid gland: a review of 106 cases. California Medicine 1957 86 1 16 19
64. Noguchi M., Yamada H., Ohta N., Regional lymph node metastases in well-differentiated thyroid carcinoma. International Surgery 1987 72 2 100 103 2-s2.0-0023217608 (Pubitemid 17115151)
65. Ahuja S., Ernst H., Lenz K., Papillary thyroid carcinoma: occurrence and types of lymph node metastases. Journal of Endocrinological Investigation 1991 14 7 543 549 2-s2.0-0025787173
66. Ito Y., Hirokawa M., Uruno T., Kihara M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology 2008 40 6 617 622 2-s2.0-50449090559 10.1080/ 00313020802320630
67. Chang H. Y., Lin J. D., Chou S. C., Chao T. C., Hsueh C., Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Japanese Journal of Clinical Oncology 2006 36 11 688 693 2-s2.0-39049176177 10.1093/jjco/hyl093
68. Liu J., Singh B., Tallini G., Carlson D. L., Katabi N., Shaha A., Tuttle R. M., Ghossein R. A., Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006 107 6 1255 1264 2-s2.0-33749012811 10.1002/cncr.22138 (Pubitemid 44452774)
69. Hagag P., Hod N., Kummer E., Cohenpour M., Horne T., Weiss M., Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up. Cancer Journal 2006 12 4 275 282 2-s2.0-33747823514 (Pubitemid 44285553)
70. Johnson T. L., Lloyd R. V., Thompson N. W., Beierwaltes W. H., Sisson J. C., Prognostic implications of the tall cell variant of papillary thyroid carcinoma. American Journal of Surgical Pathology 1988 12 1 22 27 2-s2.0-0023847728 (Pubitemid 18024370)
71. Egea A. M., Gonzalez J. M. R., Perez J. S., Cogollos T. S., Parrilla Paricio P., Prognostic value of the tall cell variety of papillary cancer of the thyroid. European Journal of Surgical Oncology 1993 19 6 517 521 2-s2.0-0027723282 (Pubitemid 24024595)
72. Michels J. J., Jacques M., Henry-Amar M., Bardet S., Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Human Pathology 2007 38 2 212 219 2-s2.0-33846231888 10.1016/j.humpath.2006.08. 001 (Pubitemid 46096555)
73. Ito Y., Hirokawa M., Fukushima M., Inoue H., Yabuta T., Uruno T., Kihara M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World Journal of Surgery 2008 32 7 1535 1543 2-s2.0-45849152093 10.1007/s00268-007-9406-7
74. Urano M., Abe M., Kuroda M., Mizoguchi Y., Horibe Y., Kasahara M., Tanaka K., Sudo K., Hirasawa Y., Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review. Pathology International 2001 51 9 707 712 2-s2.0-0034775629 10.1046/j.1440-1827.2001.01256.x (Pubitemid 32989617)
75. Baloch Z. W., LiVolsi V. A., Warthin-like papillary carcinoma of the thyroid. Archives of Pathology and Laboratory Medicine 2000 124 8 1192 1195 2-s2.0-0033838476 (Pubitemid 30650321)
76. Ludvíková M., ludvikova@fnplzen.cz Ryška A., Korabená M., Rydlová M., Michal M., Oncocytic papillary carcinoma with lymphoid stroma (Warthin-like tumour) of the thyroid: a distinct entity with favourable prognosis. Histopathology 2001 39 1 17 24 10.1046/j.1365-2559. 2001.01154.x (Pubitemid 32848270)
77. Chow S. M., Chan J. K. C., Law S. C. K., Tang D. L. C., Ho C. M., Cheung W. Y., Wong I. S. M., Lau W. H., Diffuse sclerosing variant of papillary thyroid carcinomaclinical features and outcome. European Journal of Surgical Oncology 2003 29 5 446 449 2-s2.0-0038000529 10.1016/S0748-7983(03)00005-2 (Pubitemid 36748588)
78. Lam A. K., Lo C. Y., Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Annals of Surgical Oncology 2006 13 2 176 181 2-s2.0-31544466290 10.1245/ASO.2006.03.062 (Pubitemid 43157411)
79. Falvo L., Giacomelli L., D'Andrea V., Marzullo A., Guerriero G., De Antoni E., Prognostic importance of sclerosing variant in papillary thyroid carcinoma. American Surgeon 2006 72 5 438 444 2-s2.0-33745370924 (Pubitemid 46940744)
80. Fukushima M., Ito Y., Hirokawa M., Akasu H., Shimizu K., Miyauchi A., Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World Journal of Surgery 2009 33 5 958 962 2-s2.0-67349213612 10.1007/s00268-009-9940-6
81. Lugli A., Terracciano L. M., Oberholzer M., Bubendorf L., Tornillo L., Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. Archives of Pathology and Laboratory Medicine 2004 128 1 54 58 2-s2.0-0346368243 (Pubitemid 38049567)
82. Albores-Saavedra J., Gould E., Vardaman C., Vuitch F., The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Human Pathology 1991 22 12 1195 1205 2-s2.0-0026332738 10.1016/0046-8177(91) 90101-T
83. Fukushima M., Ito Y., Hirokawa M., Kobayashi K., Miya A., Takamura Y., Akasu H., Shimizu K., Miyauchi A., Macrofollicular variant of papillary thyroid carcinoma: its clinicopathological features and long-term prognosis. Endocrine Journal 2009 56 3 503 508 2-s2.0-67650496942 10.1507/endocrj.K08E-346
84. Dalal K. M., Moraitis D., Iwamoto C., Shaha A. R., Patel S. G., Ghossein R. A., Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma. Head and Neck 2006 28 5 471 476 2-s2.0-33646362029 10.1002/hed.20383 (Pubitemid 43673083)
85. Tomoda C., Miyauchi A., Uruno T., Takamura Y., Ito Y., Miya A., Kobayashi K., Matsuzuka F., Kuma S., Kuma K., Kakudo K., Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World Journal of Surgery 2004 28 9 886 889 2-s2.0-6344277885 10.1007/s00268-004-7475-4 (Pubitemid 39391892)
86. Ito Y., Hirokawa M., Uruno T., Kihara M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Biological behavior and prognosis of encapsulated papillary carcinoma of the thyroid: experience of a Japanese hospital for thyroid care. World Journal of Surgery 2008 32 8 1789 1794 2-s2.0-48549088887 10.1007/s00268-008-9482-3
87. Baloch Z. W., baloch@mail.med.upenn.edu Shafique K., Flannagan M., LiVolsi V. A., Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study. Endocrine Practice 2010 16 6 952 959 10.4158/EP10060.OR
88. Sugitani I., Toda K., Yamamoto N., Sakamoto A., Fujimoto Y., Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country. World Journal of Surgery 2010 34 6 1265 1273 2-s2.0-77955555698 10.1007/s00268-009-0305-y
89. Volante M., Rapa I., Papotti M., Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues. Endocrine Pathology 2008 19 3 150 155 2-s2.0-58149263559 10.1007/s12022-008-9040-4
90. Hiltzik D., Carlson D. L., Tuttle R. M., Chuai S., Ishill N., Shaha A., Shah J. P., Singh B., Ghossein R. A., Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006 106 6 1286 1295 2-s2.0-33644843087 10.1002/cncr.21739 (Pubitemid 43363905)
91. Ha E. A., Ismail E., Abbas M., Ouf K., MIB-1 index, S-phase fraction, mitotic figure count, and SBR histologic grading in invasive breast carcinoma: a comparative study. Breast Journal 2001 7 2 106 110 2-s2.0-0035034350 10.1046/j.1524-4741.2001.007002106.x (Pubitemid 32381883)
92. Kurki P., Vanderlaan M., Dolbeare F., Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Experimental Cell Research 1986 166 1 209 219 2-s2.0-0022542049 (Pubitemid 16030469)
93. Cattoretti G., Becker M. H. G., Key G., Duchrow M., Schluter C., Galle J., Gerdes J., Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Journal of Pathology 1992 168 4 357 363 2-s2.0-0027057589 10.1002/path.1711680404 (Pubitemid 23013251)
94. Sullivan R. P., Mortimer G., Muircheartaigh I. O., Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression. Irish Journal of Medical Science 1993 162 9 343 347 2-s2.0-0027454216 (Pubitemid 23310941)
95. Hoyt J. W., Gown A. M., Kim D. K., Berger M. S., Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues. Journal of Neuro-Oncology 1995 24 2 163 169 2-s2.0-0029019987 10.1007/BF01078486
96. Sofiadis A., Tani E., Foukakis T., Kjellman P., Skoog L., Höög A., Wallin G., Zadenius J., Larsson C., Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy. International Journal of Oncology 2009 35 2 369 374 2-s2.0-69449101988 10.3892/ijo00000348
97. Ito Y., Miyauchi A., Kakudo K., Hirokawa M., Kobayashi K., Miya A., Prognostic significance of Ki-67 labeling index in papillary thyroid carcinoma. World Journal of Surgery 2010 34 12 3015 3021 2-s2.0-77955293477 10.1007/s00268-010-0746-3
98. Mercer K. E., Pritchard C. A., Raf proteins and cancer: B-Raf is identified as a mutational target. Biochimica et Biophysica Acta 2003 1653 1 25 40 2-s2.0-0038697566 10.1016/S0304-419X(03)00016-7 (Pubitemid 36627818)
99. Torii S., Nakayama K., Yamamoto T., Nishida E., Regulatory mechanisms and function of ERK MAP kinases. Journal of Biochemistry 2004 136 5 557 561 2-s2.0-14944350982 10.1093/jb/mvh159 (Pubitemid 40364176)
100. Kohno M., Pouyssegur J., Targeting the ERK signaling pathway in cancer therapy. Annals of Medicine 2006 38 3 200 211 2-s2.0-33646399160 10.1080/07853890600551037 (Pubitemid 43675585)
101. Garnett M. J., Marais R., Guilty as charged: B-RAF is a human oncogene. Cancer Cell 2004 6 4 313 319 2-s2.0-5444227865 10.1016/j.ccr.2004.09.022 (Pubitemid 39361432)
102. Kim K. H., Kang D. W., Kim S. H., Seong I. O., Kang D. Y., Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Medical Journal 2004 45 5 818 821 2-s2.0-9144219691 (Pubitemid 39545368)
103. Kim T. Y., Kim W. B., Rhee Y. S., Song J. Y., Kim J. M., Gong G., Lee S., Kim S. Y., Kim S. C., Hong S. J., Shong Y. K., The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clinical Endocrinology 2006 65 3 364 368 2-s2.0-33747369828 10.1111/j.1365-2265.2006.02605.x
104. Fukushima T., Suzuki S., Mashiko M., Ohtake T., Endo Y., Takebayashi Y., Sekikawa K., Hagiwara K., Takenoshita S., BRAF mutations in papillary carcinomas of the thyroid. Oncogene 2003 22 41 6455 6457 2-s2.0-0142135475 10.1038/sj.onc.1206739 (Pubitemid 37281692)
105. Namba H., Nakashima M., Hayashi T., Hayashida N., Maeda S., Rogounovitch T. I., Ohtsuru A., Saenko V. A., Kanematsu T., Yamashita S., Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism 2003 88 9 4393 4397 2-s2.0-0141453014 10.1210/jc.2003-030305 (Pubitemid 37153748)
106. Adeniran A. J., Zhu Z., Gandhi M., Steward D. L., Fidler J. P., Giordano T. J., Biddinger P. W., Nikiforov Y. E., Yuri.Nikiforov@uc.edu Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. American Journal of Surgical Pathology 2006 30 2 216 222 10.1097/01.pas.0000176432.73455.1b (Pubitemid 43740191)
107. Fugazzola L., Peuxeddu E., Avenia N., Correlation between B-RAFV600E mutation and clinicopathologic parameters in papillary thyroid carcinoma: data from a multicentric Italia study and review of the literature. Endocrine Related Cancer 2006 13 2 455 463
108. Kebebew E., Weng J., Bauer J., Ranvier G., Clark O. H., Duh Q. Y., Shibru D., Bastian B., Griffin A., The prevalence and prognostic value of BRAF mutation in thyroid cancer. Annals of Surgery 2007 246 3 466 470 2-s2.0-34548192281 10.1097/SLA.0b013e318148563d
109. Xing M., Westra W. H., Tufano R. P., Cohen Y., Rosenbaum E., Rhoden K. J., Carson K. A., Vasko V., Larin A., Tallini G., Tolaney S., Holt E. H., Hui P., Umbricht C. B., Basaria S., Ewertz M., Tufaro A. P., Califano J. A., Ringel M. D., Zeiger M. A., Sidransky D., Ladenson P. W., BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2005 90 12 6373 6379 2-s2.0-28744442816 10.1210/jc.2005-0987 (Pubitemid 41759286)
110. Yasuhiro I., Yoshida H., Maruo R., Morita S., Takano T., Hirokawa M., Yabuta T., Fukushima M., Inoue H., Tomoda C., Kihara M., Uruno T., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocrine Journal 2009 56 1 89 97 2-s2.0-62549101651 10.1507/endocrj.K08E-208
111. Lupi C., Giannini R., Ugolini C., Proietti A., Berti P., Minuto M., Materazzi G., Elisei R., Santoro M., Miccoli P., Basolo F., Extensive clinical experience: association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2007 92 11 4085 4090 2-s2.0-35948938528 10.1210/jc.2007-1179 (Pubitemid 350074715)
112. Nikiforova M. N., Kimura E. T., Gandhi M., Biddinger P. W., Knauf J. A., Basolo F., Zhu Z., Giannini R., Salvatore G., Fusco A., Santoro M., Fagin J. A., Nikiforov Y. E., BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5399 5404 2-s2.0-10744222003 10.1210/jc.2003-030838 (Pubitemid 37452745)
113. Ito Y., Hirokawa M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Prognosis and prognostic factors of follicular carcinoma in Japan: Importance of postoperative pathological examination. World Journal of Surgery 2007 31 7 1417 1424 2-s2.0-34250687538 10.1007/s00268-007-9095-2 (Pubitemid 46945384)
114. Mueller-Gaertner H. W., Brzac H. T., Rehpenning W., Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 1991 67 7 1903 1911 2-s2.0-0026087063
115. Simpson W. J., McKinney S. E., Carruthers J. S., Gospodarowicz M. K., Sutcliffe S. B., Panzarella T., Papillary and follicular thyroid cancer. American Journal of Medicine 1987 83 3 479 488 2-s2.0-0023614583
116. Shaha A. R., Loree T. R., Shah J. P., Monchick J., Cady B., Weber C., Thompson N., Boggs J., Henry J. F., Russell C., Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995 118 6 1131 1138 2-s2.0-0028827189 10.1016/S0039-6060(05)80124-2
117. Crile Jr. G., Pontius K. I., Hawk W. A., Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surgery Gynecology and Obstetrics 1985 160 5 409 413 (Pubitemid 15057832)
118. Joensuu H., Klemi P. J., Paul R., Tuominen J., Survival and prognostic factors in thyroid carcinoma. Acta Radiologica Oncology 1986 25 3 167 170 2-s2.0-0022918269
119. Zidan J., Kassem S., Kuten A., Follicular carcinoma of the thyroid gland: Prognostic factors, treatment, and survival. American Journal of Clinical Oncology 2000 23 1 1 5 2-s2.0-0034123678 10.1097/00000421-200002000-00001 (Pubitemid 30407346)
120. Witte J., Goretzki P. E., Dieken J., Simon D., Röher H. D., Importance of lymph node metastases in follicular thyroid cancer. World Journal of Surgery 2002 26 8 1017 1022 2-s2.0-0036688232 10.1007/s00268-002-6668-y (Pubitemid 36920302)
121. Besic N., Zgajnar J., Hocevar M., Frkovic-Grazio S., Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 2005 15 5 439 448 2-s2.0-20044369228 10.1089/thy.2005.15.439 (Pubitemid 40770623)
122. Chow S. M., Law S. C. K., Mendenhall W. M., Au S. K., Yau S., Yuen K. T., Law C. C., Lau W. H., Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 2002 95 3 488 498 2-s2.0-0036682380 10.1002/cncr.10683 (Pubitemid 34810173)
123. Ito Y., Fukushima M., Yabuta T., Inoue H., Uruno T., Kihara M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Miyauchi A., Prevalence and prognosis of familial follicular thyroid carcinoma. Endocrine Journal 2008 55 5 847 852 2-s2.0-55049088774 10.1507/endocrj.K08E-057
124. Lo C. Y., Chan W. F., Lam K. Y., Wan K. Y., Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Annals of Surgery 2005 242 5 708 715 2-s2.0-27644558989 10.1097/01.sla.0000186421.30982.d2 (Pubitemid 41567127)
125. Asari R., reza.asari@meduniwien.ac.at Koperek O., Scheuba C., Riss P., Kaserer K., Hoffmann M., Niederle B., Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Annals of Surgery 2009 249 6 1023 1031 10.1097/SLA.0b013e3181a77b7b
126. Yutan E., Clark O. H., Hurthle cell carcinoma. Current Treatment Options in Oncology 2001 2 4 331 335 2-s2.0-0035437003
127. Kushchayeva Y., Duh Q. Y., Kebebew E., Clark O. H., Prognostic indications for Hürthle cell cancer. World Journal of Surgery 2004 28 12 1266 1270 2-s2.0-16644373943 10.1007/s00268-004-7602-2 (Pubitemid 40941290)
128. Grant C. S., Hay I. D., Ryan J. J., Bergstralh E. J., Rainwater L. M., Goellner J. R., Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World Journal of Surgery 1990 14 3 283 290 2-s2.0-0025074278 10.1007/BF01658504 (Pubitemid 20299923)
129. Haigh P. L., philip.i.haigh@kp.org Urbach D. R., The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery 2005 138 6 1152 1158 10.1016/j.surg.2005.08.034 (Pubitemid 41797357)
130. Besic N., Auersperg M., Golouh R., Prognostic factors in follicular carcinoma of the thyroida multivariate survival analysis. European Journal of Surgical Oncology 1999 25 6 599 605 2-s2.0-0345580184 10.1053/ejso.1999.0714
131. Sugino K., Ito K., Mimura T., Kameyama K., Iwasaki H., Ito K., Hürthle cell tumor of the thyroid: analysis of 188 patients. World Journal of Surgery 2001 25 9 1160 1163 (Pubitemid 32845829)